Skip to content
  • Sunday, 26 July 2026
  • 2:10 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Johnson & Johnson’s Spravato Remission Data Takes Center Stage in Push for Treatment-Resistant Depression Growth
Laboratory Automation & Robotics

Johnson & Johnson’s Spravato Remission Data Takes Center Stage in Push for Treatment-Resistant Depression Growth

Lana Keisha Jul 19, 2026 0

A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…

Read More
Laboratory Automation & Robotics

J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push

Lana Keisha Jul 5, 2026 0

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…

Read More
Laboratory Automation & Robotics

J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push

Lana Keisha Jun 27, 2026 0

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…

Read More
Laboratory Automation & Robotics

J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push

Lana Keisha Jun 20, 2026 0

Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…

Read More
Laboratory Automation & Robotics

J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push

Lana Keisha Jun 13, 2026 0

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…

Read More
Clinical Diagnostics & Pathology

CDC Testing Pause Puts Clinical Labs at the Center of Public Health Response

Reynand Amr Wu May 24, 2026 0

The Centers for Disease Control and Prevention (CDC) has implemented a temporary suspension of its infectious disease testing services for…

Read More
Clinical Diagnostics & Pathology

CDC Testing Pause Puts Clinical Labs at the Center of Public Health Response

Reynand Amr Wu May 9, 2026 0

A temporary suspension of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has initiated a…

Read More
Advanced Materials Science

A New Two-Component Dark Matter Model Explains the Galactic Center Gamma-Ray Excess While Reconciling the Absence of Signals in Dwarf Galaxies

Nila Kartika Wati May 4, 2026 0

The search for dark matter, the invisible substance believed to constitute approximately 85% of the matter in the universe, has…

Read More
Advanced Materials Science

Breakthrough in Piezoelectric Chip Design Promises to Revolutionize Data Center Energy Efficiency and GPU Power Delivery

Nila Kartika Wati Apr 26, 2026 0

As the global appetite for artificial intelligence and cloud computing continues to accelerate, the infrastructure supporting these technologies is facing…

Read More
Advanced Materials Science

The Galactic Center Excess and the Mystery of Two-Component Dark Matter: New Research Explains the Silence of Dwarf Galaxies

Nila Kartika Wati Apr 18, 2026 0

The pursuit of dark matter remains one of the most profound challenges in modern astrophysics, as this invisible substance is…

Read More

Posts pagination

1 2
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Galahadcorvus rhysi: A Swift, Land-Dwelling Predator Emerges from the Triassic of GloucesterEClinical Solutions study models 241% ROI from AI-powered clinical trial data platformUnlocking Photosynthetic Efficiency: Hornworts Offer a Molecular Blueprint for Supercharged Crops
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ